Adicet Bio (STU:1IJA) Operating Cash Flow per Share : €-1.76 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Adicet Bio Operating Cash Flow per Share?

Adicet Bio's operating cash flow per share for the three months ended in Mar. 2024 was €-0.27. Adicet Bio's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.76.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Adicet Bio's Operating Cash Flow per Share or its related term are showing as below:

STU:1IJA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -21.1 Med: 8.5 Max: 27.3
Current: 27.3

During the past 6 years, Adicet Bio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.30% per year. The lowest was -21.10% per year. And the median was 8.50% per year.

STU:1IJA's 3-Year OCF Growth Rate is ranked better than
77.18% of 1240 companies
in the Biotechnology industry
Industry Median: 3.55 vs STU:1IJA: 27.30

Adicet Bio Operating Cash Flow per Share Historical Data

The historical data trend for Adicet Bio's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicet Bio Operating Cash Flow per Share Chart

Adicet Bio Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.28

-4.67

-1.46

-1.03

-2.00

Adicet Bio Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.52	-0.54	-0.46	-0.50	-0.27

Competitive Comparison of Adicet Bio's Operating Cash Flow per Share

For the Biotechnology subindustry, Adicet Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adicet Bio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adicet Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Adicet Bio's Price-to-Operating-Cash-Flow falls into.

Adicet Bio Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Adicet Bio's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-85.938	/	43.042
	=	-2.00

Adicet Bio's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-21.021	/	79.072
	=	-0.27

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.76

Adicet Bio Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Adicet Bio's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicet Bio (STU:1IJA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adicet Bio Inc (STU:1IJA) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ACET:USA 1IJA:Germany

Address

200 Clarendon Street, Floor 6, Boston, MA, USA, 02116

Website

https://www.adicetbio.com

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company operates and manages its business as one reportable and operating segment, which is the business of research and development of allogeneic immunotherapies for cancer and other diseases.

Adicet Bio (STU:1IJA) Headlines

No Headlines